drugset / Trial / NCT00113737

Fluoxetine as a Quit Smoking AID for Depression Prone

NCT00113737

Double-blindPrevention

Summary

To test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improves the depression-prone smoker's ability to quit.

Timeline

Start
1998-02
Primary completion
Completion
2002-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 60 mg

Indications